Progress in diagnosis and treatment of gastroparesis after colon cancer surgery.
10.3760/cma.j.cn441530-20220519-00221
- Author:
Zhi Zhong PAN
1
;
Long YU
1
;
Jian Hong PENG
1
Author Information
1. Department of Colorectal Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
- Publication Type:Review
- Keywords:
Colon neoplasms;
Gastroparesis syndrome;
Pathogenesis;
Risk factors
- MeSH:
Colonic Neoplasms/surgery*;
Digestive System Surgical Procedures/adverse effects*;
Gastroparesis/therapy*;
Humans;
Neoplasm Recurrence, Local
- From:
Chinese Journal of Gastrointestinal Surgery
2022;25(6):558-562
- CountryChina
- Language:Chinese
-
Abstract:
At present, comprehensive treatment dominated by surgical procedures is an important measure for colon cancer to obtain the chance of cure. Surgical intervention, while removing the tumor, carries the risk of postoperative gastroparesis (PG) . Because of the low incidence rate and insignificant early clinical symptoms, early stage PG is often overlooked clinically. However, PG can increase the risk of malnutrition, delay postoperative antitumor treatment, and increase the risk of tumor recurrence and metastasis. This review focuses on the mechanisms, clinical risk factors, preventive measures, and advances in treatment of PG due to colon cancer. Aim to increase the clinician's adequate attention to PG in colon cancer and from a surgical point to reduce the risk of gastroparesis in colon cancer by optimizing the surgical strategy.
